ALK and non-small cell lung carcinoma: Among patients with advanced ALK-positive NSCLC, tumor characteristics in the central nervous system, patterns of disease evolution in the brain, and eligibilities for stereotactic radiotherapy, in the baseline or after certain treatment, have not been fully elucidated.